Discovery of novel imaging biomarkers for cardiotoxicity in a prospective longitudinal study of cancer patients receiving anthracyclines and chest radiotherapy

Back

ESC2025 Premium Access

Discovery of novel imaging biomarkers for cardiotoxicity in a prospective longitudinal study of cancer patients receiving anthracyclines and chest radiotherapy

Session: Cardio-immuno-oncology

Topic: Cardio-Oncology

Speaker: Doctor G. Ntentas (London, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Georgios Ntentas

Guy's and St Thomas' NHS Trust Hospitals, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Cardiovascular magnetic resonance vs. echocardiography for assessing baseline cardiovascular reserve in patients undergoing CAR-T therapy

Speaker: Doctor B. Aumente Rodriguez (Salamanca, ES)

Increased cardiovascular risk and cardiac dysfunction in cancer survivors from UK Biobank

Speaker: Ms G. Andriamiadana (London, GB)

Longitudinal changes in right ventricular function in breast cancer patients undergoing cardiotoxic chemotherapy

Speaker: Doctor E. Guerra (Tlalpan, MX) Doctor N. Espinola-Zavaleta (Mexico City, MX)

Treatment response in light chain cardiac amyloidosis improves left ventricular arterial coupling.

Speaker: Associate Professor A. Briasoulis (Athens, GR)

MicroRNA signatures and machine learning models for predicting cardiotoxicity in HER2 positive breast cancer patients

Speaker: Doctor E. Oikonomou (Athens, GR)

Access the full session

Cardio-immuno-oncology

Speakers: Doctor G. Ntentas, Doctor B. Aumente Rodriguez, Ms G. Andriamiadana, Doctor E. Guerra, Doctor N. Espinola-Zavaleta...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources